● Recruiting

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

Condition: Refractory Angina · Sponsor: Tel-Aviv Sourasky Medical Center

PhaseNA

Planned participants100

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to implant the Reducer in patients with the symptoms of refractory angina, that suffer from refractory angina who demonstrate reversible ischemia.

This description comes directly from the study's public registry record.

Talk to the study team

Shmuel Banai, Prof. · 972-3-6973395 · shmuelb@tasmc.health.gov.il

Gad Keren, Prof. · 972-3-6974762 · gadk@tasmc.health.gov.il

Always discuss trial participation with your own doctor first.

Locations (2)

Tel Aviv Sourasky Medical Center	Tel Aviv, Israel	Recruiting
Tel Aviv Medical Center	Tel Aviv, Israel	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01566175